ArticleEuropean journal of neurology2025
Free Water as a Marker of Early Small Vessel Disease in Healthy Aging.
Article in European journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundBrain aging is associated with cerebrovascular changes and related microstructural pathology. In this context, research indicates that small vessel disease (SVD) is characterized by increases in extracellular free water (FW).
methodsWe examined 94 individuals with early signs of small vessel disease (eSVD; M
resultsDifferences between individuals with eSVD and CON were identified for FW in NAWM and FW-uncorrected DTI, but not for FW-corrected DTI measures. Both FW and FW-uncorrected DTI measures in NAWM were significantly associated with age across the total sample (r
conclusionsEven in subjects with subtle, clinically silent, cerebral white matter changes, increases in FW could be observed compared to individuals without those changes. Therefore, FW might act as a sensitive marker at the earliest signs of SVD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.